Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 14
Submit an article Journal homepage
192
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis

Aidan M. Kirkhama Clinical Epidemiology & Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Canada;b Faculty of Medicine, Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Canada
,
Adrian J. M. Baileya Clinical Epidemiology & Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Canada;c Faculty of Medicine, University of Ottawa, Ottawa, Canada
,
Ashish Masurekara Clinical Epidemiology & Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Canada;d Transplant and Cellular Therapy Division, The Ottawa Hospital, Ottawa, Canada;e Department of Medicine, The Ottawa Hospital, Ottawa, Canada
,
Risa Shorrf Medical Information and Learning Services Division, The Ottawa Hospital, Ottawa, Canada
,
Christopher Bredesona Clinical Epidemiology & Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Canada;c Faculty of Medicine, University of Ottawa, Ottawa, Canada;d Transplant and Cellular Therapy Division, The Ottawa Hospital, Ottawa, Canada;e Department of Medicine, The Ottawa Hospital, Ottawa, Canada
,
Mitchell Sabloffa Clinical Epidemiology & Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Canada;c Faculty of Medicine, University of Ottawa, Ottawa, Canada;e Department of Medicine, The Ottawa Hospital, Ottawa, Canada;g Leukemia Program, The Ottawa Hospital, Ottawa, CanadaORCID Iconhttps://orcid.org/0000-0002-0122-6138
ORCID Icon &
David S. Allana Clinical Epidemiology & Regenerative Medicine, Ottawa Hospital Research Institute, Ottawa, Canada;b Faculty of Medicine, Department of Biochemistry, Microbiology & Immunology, University of Ottawa, Ottawa, Canada;c Faculty of Medicine, University of Ottawa, Ottawa, Canada;d Transplant and Cellular Therapy Division, The Ottawa Hospital, Ottawa, Canada;e Department of Medicine, The Ottawa Hospital, Ottawa, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3261-8289
ORCID Icon show all
Pages 3276-3287 | Received 09 May 2022, Accepted 18 Aug 2022, Published online: 13 Sep 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.